- Home
- CLWT vs NERV Comparison
CLWT vs NERV Comparison
Compare CLWT & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLWT
- NERV
- Stock Information
- Founded
- CLWT 1971
- NERV 2007
- Country
- CLWT Hong Kong
- NERV United States
- Employees
- CLWT N/A
- NERV N/A
- Industry
- CLWT Professional and commerical equipment
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- CLWT Consumer Discretionary
- NERV Health Care
- Exchange
- CLWT Nasdaq
- NERV Nasdaq
- Market Cap
- CLWT 8.9M
- NERV 10.3M
- IPO Year
- CLWT 1997
- NERV 2014
- Fundamental
- Price
- CLWT $1.20
- NERV $1.78
- Analyst Decision
- CLWT
- NERV Hold
- Analyst Count
- CLWT 0
- NERV 1
- Target Price
- CLWT N/A
- NERV $5.00
- AVG Volume (30 Days)
- CLWT 8.5K
- NERV 18.1K
- Earning Date
- CLWT 04-29-2025
- NERV 05-05-2025
- Dividend Yield
- CLWT 6.41%
- NERV N/A
- EPS Growth
- CLWT 630.02
- NERV N/A
- EPS
- CLWT 0.28
- NERV 0.19
- Revenue
- CLWT $17,242,000.00
- NERV N/A
- Revenue This Year
- CLWT N/A
- NERV N/A
- Revenue Next Year
- CLWT N/A
- NERV N/A
- P/E Ratio
- CLWT $4.53
- NERV $9.00
- Revenue Growth
- CLWT 6.59
- NERV N/A
- 52 Week Low
- CLWT $1.02
- NERV $1.15
- 52 Week High
- CLWT $1.94
- NERV $3.69
- Technical
- Relative Strength Index (RSI)
- CLWT 50.33
- NERV 59.64
- Support Level
- CLWT $1.09
- NERV $1.52
- Resistance Level
- CLWT $1.20
- NERV $1.81
- Average True Range (ATR)
- CLWT 0.08
- NERV 0.17
- MACD
- CLWT 0.02
- NERV 0.04
- Stochastic Oscillator
- CLWT 75.00
- NERV 95.45
About CLWT Euro Tech Holdings Company Limited
Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.